Chemokine monocyte chemoattractant protein-3 in progressive periodontal lesions in patients with chronic periodontitis

Journal of Periodontology

Volumn 81, Issue 2, 2010, Pages 267-276

  Dezerega, Andrea ^a   Pozo, Patricia ^b   Hernández, Marcela ^a   Oyarzún, Alejandro ^c   Rivera, Oriana ^a   Dutzan, Nicolás ^a   Gutiérrez Fernández, Ana ^d   Overall, Christopher M ^e   Garrido, Mauricio ^a   Alcota, Marcela ^a   Ortiz, Emilio ^a   Gamonal, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD CATÓLICA DEL NORTE   (Chile)

^c UNIVERSIDAD FINIS TERRAE   (Chile)

^d UNIVERSITY OF OVIEDO   (Spain)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CCL7; Chemokine; Chronic periodontitis; Cytokine; MCP 3; Periodontitis

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 3;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GINGIVA; GINGIVITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LONGITUDINAL STUDY; MALE; METABOLISM; MIDDLE AGED; REFERENCE VALUE;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINE CCL7; CHI-SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; DISEASE PROGRESSION; FEMALE; GINGIVA; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 77649230693     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090406     Document Type: Article

References (53)

1. Armitage GG. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontol 1986;13:418-430.
3. American Academy of Periodontology. Diagnosis of periodontal diseases (position paper). J Periodontol 2003; 74:1237-1247.
4. Zappa U, Reinking-Zappa M, Graf H, Espeland M. Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 1991;18:508-515.
5. Saglie FR, Pertuiset J, Rezende MT, Nester M, Marfany A, Cheng J. In situ correlative immune-identification of mononuclear infiltrates and invasive bacteria in diseased gingiva. J Periodontol 1988;59:688-696.
6. Offenbacher S. Periodontal disease: Pathogenesis. Ann Periodontol 1996;1:821-878.
7. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26:230-242.
8. Adams DH, Lloyd AR. Chemokines: Leucocyte recruitment and activation cytokines. Lancet 1997; 349:490-495.
9. Furutani Y, Nomura H, Notake M, et al. Cloning and sequencing of the cDNA for human monocyte chemotactic and activation factor (MCAF). Biochem Biophys Res Commun 1989;159:249-255.
10. van Damme J, Proust P, Lenaeris JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992;176:59-65.
11. Uguccioni M. Monocyte chemotactic protein 4 (MCP- 4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 1996;183:2379-2384.
12. Ben-Baruch A, Xu L, Young PR, Bengali K, Oppenheim JJ,Wang JM. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J Biol Chem 1995;270:22123-22128.
13. Pype JL, Dupont LJ, Menten P, et al. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 1999;21:528-536.
14. Hanazawa S, Kawara Y, Takeshita A, et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease. Increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissue. Infect Immun 1993;61:5219-5224.
15. Tonetti MS, Imboden MA, Gerber L, Lang NP, Laissue J, Mueller C. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun 1994;62:4005-4014.
16. Haffajee AD, Socransky SS, Goodson JM. Comparison of different data analysis for detection changes in attachment levels. J Clin Periodontol 1983;10:298-310.
17. Colotta F, Borre A, Wang JM, et al. Expression of monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 1992;148:760-765.
18. Polentarutti N, Introna M, Sozzani S, Mancinelli R, Mantovani G, Mantovani A. Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur Cytokine Netw 1997;8:271-274.
19. Vouret-Craviari V, Cenzuales S, Poli G, Mantovani A. Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Cytokine 1997; 9:992-998.
20. Menten P, Proost P, Struyf S, et al. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Eur J Immunol 1999;29:678-685.
21. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study. J Neuroimmunol 1998 1;86:20-29
22. Uguccioni M, Gionchetti P, Robbiani DF, et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999;155:331-336.
23. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003;199:28-35.
24. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T. Purification and partial sequence of human osteoclastactivating factor: Identity with interleukin-1B. J Immunol 1985;135:2562-2568.
25. Matsuki Y, Yamamoto T, Hara K. Interleukin-1 mRNA-expressing macrophages in human chronically inflamed gingival tissues. Am J Pathol 1991;138: 1299-1308.
26. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingival by combined in situ hybridization and immunohistochemistry. Immunology 1992;76:42-47.
27. Masada M, Persson R, Kenney J, Lee S, Page R, Allison A. Measurement of interleukin-1a and -B in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. J Periodont Res 1990;25:156-163.
28. Reinhardt RA, Masada MP, Kaldahl WB, et al. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 1993;20:225-231.
29. Stashenko P, Fukiyoshi P, Obernesser M, Prostak L, Haffajee A, Socransky S. Levels of interleukin-1B in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
30. Billiau A, Dijkmans R. Interferon-g: Mechanism of action and therapeutic potential. Biochem Pharmacol 1990;40:1433-1439.
31. Takayanagi H, Sato K, Takaoka A, Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 2005;208: 181-193.
32. Ukai T, Mori Y, Onoyama M, Hara Y. Immunohistological study of interferon-gamma and interleukin-4- bearing cells in human periodontitis gingiva. Arch Oral Biol 2001;46:901-908.
33. Roberts FA, McCaffery KA, Michalek AM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 1997;76:1833-1839.
34. Xu LL, McVicar DW, Ben-Baruch A, et al. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: Binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol 1995;25:2612-2617.
35. Nakashima K, Giannopoulou C, Andersen E, et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996;23:832-838.
36. McCauley LK, Nohutcu RM. Mediators of periodontal osseous destruction and remodeling: Principles and implications for diagnosis and therapy. J Periodontol 2002;73:1377-1391.
37. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic test. Ann Periodontol 1997;2:123-137.
38. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1b, -8, -10 and RANTES in gingival crevicular fluid and cell populations in adult patients with destructive periodontitis and the effect of periodontal treatment. J Periodontol 2000;71:1535-1545.
39. Gamonal J, Bascones A, Jorge O, Silva A. Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis. J Clin Periodontol 2000;27:675-681.
40. Lindhe J, Okamoto H, Yoneyama T, Haffajee A, Socransky SS. Longitudinal changes in periodontal disease in untreated subjects. J Clin Periodontol 1989;16:662-670.
41. Hugosan A, Laurell L. A prospective longitudinal study on periodontal bone height changes in a Swedish populations. J Clin Periodontol 2000;27:665-674.
42. Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982;9:472-481.
43. Zappa U, Simona C, Schäppi P, Graf H, Espeland M. Episodic probing attachment loss in humans: Histologic associations. J Periodontol 1990;61:420-426.
44. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994;5:112-141.
45. Silva N, Dutzan N, Hernandez M, et al. Characterization of progressive periodontal lesions in chronic periodontitis patients: Levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 2008;35:206-214.
46. Wetzel K, Struyf S, Van Damme J, et al. MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells. Int J Cancer 2007;120: 1364-1371.
47. Ong VH, Evans LA, Shiwen X, et al. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 fight-skin mouse. Arthritis Rheum 2003;48:1979-1991.
48. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol 2000;192:4-13.
49. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie M, Martin T. Modulation of osteoclasts differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20:345-357.
50. Yu X, Huang Y, Collin-Osdoby P, Osdoby P. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 2004;19:2065-2077.
51. Szekanecz Z, Kim J, Koch AE. Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 2003;15:15-21.
52. Vernal R, Dutzan N, Hernandez M, et al. High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+T lymphocytes. J Periodontol 2006;77:1772-1780.
53. Viola A, Luster A. Chemokines and their receptors: Drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008;48:171-197.